Outcomes of febrile events in pediatric patients with sickle cell anemia

被引:9
作者
Sirigaddi, Krishnaveni [1 ]
Aban, Inmaculada [2 ]
Jantz, Amelia [1 ]
Pernell, Brandi M. [1 ]
Hilliard, Lee M. [1 ]
Bhatia, Smita [1 ,3 ]
Lebensburger, Jeffrey D. [1 ]
机构
[1] Univ Alabama Birmingham, Dept Pediat, Div Pediat Hematol Oncol, Birmingham, AL USA
[2] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Inst Canc Outcomes & Survivorship, Birmingham, AL USA
关键词
bacteremia; fever; infection; outcomes; sickle cell anemia; PNEUMOCOCCAL CONJUGATE VACCINE; HOSPITAL EMERGENCY-DEPARTMENT; OUTPATIENT MANAGEMENT; BLOOD CULTURES; YOUNG-CHILDREN; DISEASE; BACTEREMIA; PREDICTORS; INFANTS; FEVER;
D O I
10.1002/pbc.27379
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundLimited evidence exists to create institutional admission criteria guidelines for febrile sickle cell patients. In addition, evidence is lacking to understand readmission rates for febrile sickle cell patients discharged from the emergency department (ED) or hospital. ProceduresWe conducted a 16-year retrospective study of bacteremia outcomes for febrile sickle cell patients. Risk variables analyzed included fever (either39.5 degrees C or 40 degrees C), abnormal white blood cell (WBC) (>30,000 or<5,000/mcL), tachycardia and hypotension, or ill appearing. Fourteen-day readmission rates were analyzed to determine outcomes for febrile sickle cell patients discharged from the ED or discharged within 72h. ResultsBacteremia was identified in 17 (2.6%) of 653 febrile events that are presented to the ED. Ill-appearing patients had an 8.5-fold increased odds of being diagnosed with bacteremia. Models using WBC count, ill appearing, and hypotension have the highest sensitivity and specificity (AUC>0.75). Among 427 patients discharged from the ED or within 72h of hospitalization, only 10 (2.3%) were readmitted for a new sickle cell complication. ConclusionsInstitutions can develop admission criteria based on WBC count, hypotension, and ill appearance. Persistently febrile, well-appearing patient can be discharged at 48h with minimal risk for new complications.
引用
收藏
页数:7
相关论文
共 27 条
[1]   Incidence of Serious Bacterial Infections in Febrile Children With Sickle Cell Disease [J].
Bansil, Nelson H. ;
Kim, Tommy Y. ;
Tieu, Linh ;
Barcega, Besh .
CLINICAL PEDIATRICS, 2013, 52 (07) :661-666
[2]   Bacteremia Risk and Outpatient Management of Febrile Patients With Sickle Cell Disease [J].
Baskin, Marc N. ;
Goh, Xin Lyn ;
Heeney, Matthew M. ;
Harper, Marvin B. .
PEDIATRICS, 2013, 131 (06) :1035-1041
[3]   ANTIBODY-RESPONSES TO POLYVALENT PNEUMOCOCCAL VACCINE IN INFANTS WITH SICKLE-CELL-ANEMIA [J].
BUCHANAN, GR ;
SCHIFFMAN, G .
JOURNAL OF PEDIATRICS, 1980, 96 (02) :264-266
[4]   Predictors for Bacteremia in Febrile Sickle Cell Disease Children in the Post-7-Valent Pneumococcal Conjugate Vaccine Era [J].
Chang, Todd P. ;
Kriengsoontorkij, Worapant ;
Chan, Linda S. ;
Wang, Vincent J. .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2013, 35 (05) :377-382
[5]   13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study [J].
De Montalembert, Mariane ;
Abboud, Miguel R. ;
Fiquet, Anne ;
Inati, Adlette ;
Lebensburger, Jeffrey D. ;
Kaddah, Normeen ;
Mokhtar, Galila ;
Piga, Antonio ;
Halasa, Natasha ;
Inusa, Baba ;
Rees, David C. ;
Heath, Paul T. ;
Telfer, Paul ;
Driscoll, Catherine ;
Al Hajjar, Sami ;
Tozzi, Alberto ;
Jiang, Qin ;
Emini, Emilio A. ;
Gruber, William C. ;
Gurtman, Alejandra ;
Scott, Daniel A. .
PEDIATRIC BLOOD & CANCER, 2015, 62 (08) :1427-1436
[6]   PROPHYLAXIS WITH ORAL PENICILLIN IN CHILDREN WITH SICKLE-CELL-ANEMIA - A RANDOMIZED TRIAL [J].
GASTON, MH ;
VERTER, JI ;
WOODS, G ;
PEGELOW, C ;
KELLEHER, J ;
PRESBURY, G ;
ZARKOWSKY, H ;
VICHINSKY, E ;
IYER, R ;
LOBEL, JS ;
DIAMOND, S ;
HOLBROOK, CT ;
GILL, FM ;
RITCHEY, K ;
FALLETTA, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (25) :1593-1599
[7]   CLINICAL EVENTS IN THE FIRST DECADE IN A COHORT OF INFANTS WITH SICKLE-CELL DISEASE [J].
GILL, FM ;
SLEEPER, LA ;
WEINER, SJ ;
BROWN, AK ;
BELLEVUE, R ;
GROVER, R ;
PEGELOW, CH ;
VICHINSKY, E .
BLOOD, 1995, 86 (02) :776-783
[8]   Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine [J].
Halasa, Natasha B. ;
Shankar, Sadhna M. ;
Talbot, Thomas R. ;
Arbogast, Patrick G. ;
Mitchel, Ed F. ;
Wang, Winfred C. ;
Schaffner, William ;
Craig, Allen S. ;
Griffin, Marie R. .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (11) :1428-1433
[9]   Maintaining High Level of Care at Satellite Sickle Cell Clinics [J].
Hamm, Jennifer ;
Hilliard, Lee ;
Howard, Thomas ;
Lebensburger, Jeffrey .
JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2016, 27 (01) :280-292
[10]  
LEIKIN SL, 1989, PEDIATRICS, V84, P500